ECL
55
-2
DGX
48
11
PYPL
52
-2
COF
62
3
JNPR
50
-6
EW
32
3
R
70
-3
FRT
41
-2
PFE
14
-7
D
40
2
CL
54
3
AON
54
2
XOM
42
-6
ZBH
65
3
AAP
35
-9
INTU
58
-3
SCHW
62
-2
T
48
3
CAT
59
-2
CNP
54
10
ECL
55
-2
DGX
48
11
PYPL
52
-2
COF
62
3
JNPR
50
-6
EW
32
3
R
70
-3
FRT
41
-2
PFE
14
-7
D
40
2
CL
54
3
AON
54
2
XOM
42
-6
ZBH
65
3
AAP
35
-9
INTU
58
-3
SCHW
62
-2
T
48
3
CAT
59
-2
CNP
54
10
Financhill
Back

Amphastar Pharmaceuticals Quote, Financials, Valuation and Earnings

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Buy
56

AMPH
Amphastar Pharmaceuticals

Last Price:
44.58
Seasonality Move:
6.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Amphastar Pharmaceuticals Price Quote

$44.58
-0.03 (-1.07%)
(Updated: November 16, 2024 at 5:07 AM ET)

Amphastar Pharmaceuticals Key Stats

Buy
56
Amphastar Pharmaceuticals (AMPH) is a Buy
Day range:
$43.88 - $45.39
52-week range:
$36.56 - $65.92
Dividend yield:
0%
P/E ratio:
17.16
P/S ratio:
3.24
P/B ratio:
2.95%
Volume:
408.5K
Avg. volume:
353.5K
1-year change:
-22.44%
Market cap:
$2.1B
Revenue:
$644.4M
EPS:
$3

How Much Does Amphastar Pharmaceuticals Make?

Is Amphastar Pharmaceuticals Growing As A Company?

Amphastar Pharmaceuticals Stock Price Performance

What Is Amphastar Pharmaceuticals 52-Week High & Low?

Amphastar Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Amphastar Pharmaceuticals?

Is Amphastar Pharmaceuticals Cash Flow Positive?

  • What Is AMPH Cash Flow From Operations?
    Cash flow from operations (TTM) is $208.2M
  • What Is Amphastar Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$94.2M
  • What Is Amphastar Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$192.3M

Amphastar Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    AMPH return on invested capital is 12.41%
  • What Is Amphastar Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 10.28%
  • What Is AMPH Return On Equity?
    ROE is a measure of profitability and is 23.56%

Amphastar Pharmaceuticals Earnings Date & Stock Price

Amphastar Pharmaceuticals Competitors

Amphastar Pharmaceuticals Dividend Yield

Amphastar Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: -14.29% -2.14%
Revenue: 5.9% -1.79%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 59.00
Upside from Last Price: 32.26%

Major Shareholders

  • How many AMPH shares are owned by institutional investors?
    58.9M AMPH shares are owned by institutional investors
  • How many AMPH shares are owned by insiders?
    1.1M AMPH shares are owned by insiders